Table 1 Clinicopathological features of lung cancer patients in the study.
From: A highly sensitive and specific real-time quantitative PCR for BRAF V600E/K mutation screening
Variable | Group | No. (%) |
|---|---|---|
Age | Median | 65 |
|  | Range | 33–96 |
Gender | Male | 164 (53.6) |
| Â | Female | 142 (46.4) |
Smoking# | Never or light | 203 (66.3) |
| Â | Heavy | 103 (33.7) |
Stage | IA | 36 (11.7) |
| Â | IB | 74 (24.2) |
| Â | IIA | 18 (5.9) |
| Â | IIB | 18 (5.9) |
| Â | IIIA | 44 (14.4) |
| Â | IIIB | 15 (4.9) |
| Â | IV | 101 (33.0) |
Histology | Adeno | 242 (79.1) |
| Â | Squamous | 32 (10.4) |
| Â | Adenosquamous | 7 (2.3) |
| Â | Large | 6 (2.0) |
| Â | Sarcomatoid | 5 (1.6) |
| Â | Others | 14 (4.6) |
Total | Â | 306 (100) |
